Asthma

April 21, 2022

Pediatric severe asthma is a heterogeneous disease and based on data, a multi-disciplinary approach can improve the diagnosis and management of these children.

April 14, 2022

Five phenotype clusters were discovered to be associated with the exacerbation, or worsening, of chronic inflammatory airway diseases of asthma and chronic obstructive pulmonary disease (COPD), according to a recent study published in PLOS ONE.

March 19, 2022

FDA approves first generic of Symbicort for asthma and COPD and first therapy for rare seizure disorder, Rinvoq and Lynparza get nods for new indications, the agency approves a new delivery system for Alzheimer’s therapy, regulators extend review for Opzelura for skin condition and issue CRL for Fasenra for chronic rhinosinusitis.

November 27, 2021

Non-hospitalized symptomatic COVID-19 patients who were treated with ciclesonide to alleviate early symptoms did not see any difference in results compared to patients who were treated with a placebo of the drug.

November 23, 2021

Young adults with asthma were recently surveyed on their preparation of the transition to adult asthma care. Half of all those surveyed did not remember being introduced to concepts of transitioning care, including asthma self-management, by their pediatric asthma provider.

November 15, 2021

Psoriasis medicine containing risankizumab, worsened symptoms in patients with severe asthma.